Suchergebnisse - "Heneka, Michael"

PubPharm (18)

1

Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease

enthalten in: Annals of clinical and translational neurology | 2021

von Bergström, S. | Remnestål, J. | Yousef, J. | +18

2

Minor neuropsychological deficits in patients with subjective cognitive decline

enthalten in: Neurology | 2020

von Wolfsgruber, S. | Kleineidam, L. | Guski, J. | +128

3

Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults

enthalten in: The Journal of neuroscience : the official journal of the Society for Neuroscience | 2019

von Berron, D. | Cardenas-Blanco, A. | Bittner, D. | +10

4

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

enthalten in: Alzheimer's research & therapy | 2019

von Miebach, L. | Wolfsgruber, S. | Polcher, A. | +32

5

Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline : cross-sectional comparison of three European memory clinic samples

enthalten in: Alzheimer's research & therapy | 2019

von Wolfsgruber, S. | Molinuevo, J. | Wagner, M. | +21

6

The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP)

enthalten in: Neuropharmacology | 2018

von Rammes, G. | Seeser, F. | Mattusch, K. | +6

7

Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis

enthalten in: Journal of neuroinflammation | 2018

von Kalinin, S. | González-Prieto, M. | Scheiblich, H. | +6

8

Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease

enthalten in: Journal of Alzheimer's disease : JAD | 2018

von Teipel, S. | Metzger, C. | Brosseron, F. | +24

9

Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease

enthalten in: PloS one | 2015

von Bach, J. | Gold, M. | Mengel, D. | +18

10

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

enthalten in: Human molecular genetics | 2014

von Ramirez, A. | van der Flier, W. | Herold, C. | +36